HALOZYME THERAPEUTICS INC (HALO) Stock Fundamental Analysis
USA - NASDAQ:HALO - US40637H1095 - Common Stock
77.81 USD
+1.13 (+1.47%)
77.81 USD
0 (0%)
Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 540 industry peers in the Biotechnology industry. HALO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HALO has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make HALO a good candidate for value and growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year HALO was profitable.
In the past year HALO had a positive cash flow from operations.
Each year in the past 5 years HALO has been profitable.
In the past 5 years HALO always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 27.13%, HALO belongs to the best of the industry, outperforming 97.78% of the companies in the same industry.
HALO has a Return On Equity of 167.48%. This is amongst the best in the industry. HALO outperforms 99.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 28.55%, HALO belongs to the top of the industry, outperforming 98.70% of the companies in the same industry.
HALO had an Average Return On Invested Capital over the past 3 years of 17.81%. This is in line with the industry average of 15.95%.
The last Return On Invested Capital (28.55%) for HALO is above the 3 year average (17.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROIC | 28.55% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
The Profit Margin of HALO (47.28%) is better than 98.89% of its industry peers.
In the last couple of years the Profit Margin of HALO has declined.
HALO's Operating Margin of 57.92% is amongst the best of the industry. HALO outperforms 99.81% of its industry peers.
HALO's Operating Margin has declined in the last couple of years.
HALO has a Gross Margin of 84.20%. This is amongst the best in the industry. HALO outperforms 87.22% of its industry peers.
HALO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% |
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HALO is creating value.
HALO has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HALO has been reduced compared to 5 years ago.
Compared to 1 year ago, HALO has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.62 indicates that HALO is not in any danger for bankruptcy at the moment.
The Altman-Z score of HALO (5.62) is better than 76.85% of its industry peers.
HALO has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as HALO would need 2.79 years to pay back of all of its debts.
HALO has a Debt to FCF ratio of 2.79. This is amongst the best in the industry. HALO outperforms 94.07% of its industry peers.
A Debt/Equity ratio of 4.54 is on the high side and indicates that HALO has dependencies on debt financing.
HALO has a worse Debt to Equity ratio (4.54) than 82.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 5.62 |
ROIC/WACC3.18
WACC8.98%
2.3 Liquidity
A Current Ratio of 8.36 indicates that HALO has no problem at all paying its short term obligations.
The Current ratio of HALO (8.36) is better than 74.81% of its industry peers.
A Quick Ratio of 7.01 indicates that HALO has no problem at all paying its short term obligations.
HALO has a Quick ratio of 7.01. This is in the better half of the industry: HALO outperforms 69.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.41% over the past year.
The Earnings Per Share has been growing by 30.12% on average over the past years. This is a very strong growth
Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 34.97%.
Measured over the past years, HALO shows a very strong growth in Revenue. The Revenue has been growing by 38.95% on average per year.
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
3.2 Future
Based on estimates for the next years, HALO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.63% on average per year.
The Revenue is expected to grow by 12.63% on average over the next years. This is quite good.
EPS Next Y47.96%
EPS Next 2Y38.15%
EPS Next 3Y32.51%
EPS Next 5Y17.63%
Revenue Next Year31.57%
Revenue Next 2Y27.35%
Revenue Next 3Y23.97%
Revenue Next 5Y12.63%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.02, the valuation of HALO can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 95.56% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of HALO to the average of the S&P500 Index (27.38), we can say HALO is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 9.64, the valuation of HALO can be described as reasonable.
HALO's Price/Forward Earnings ratio is rather cheap when compared to the industry. HALO is cheaper than 97.04% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. HALO is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.02 | ||
| Fwd PE | 9.64 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 95.37% of the companies listed in the same industry.
HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 96.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.83 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HALO has an outstanding profitability rating, which may justify a higher PE ratio.
HALO's earnings are expected to grow with 32.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y38.15%
EPS Next 3Y32.51%
5. Dividend
5.1 Amount
HALO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
77.81
+1.13 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners100.38%
Inst Owner Change5.29%
Ins Owners0.82%
Ins Owner Change0.1%
Market Cap9.10B
Analysts75
Price Target72.93 (-6.27%)
Short Float %10.28%
Short Ratio6.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.03%
Min EPS beat(2)14.79%
Max EPS beat(2)19.26%
EPS beat(4)4
Avg EPS beat(4)16.87%
Min EPS beat(4)6.64%
Max EPS beat(4)26.79%
EPS beat(8)7
Avg EPS beat(8)12.25%
EPS beat(12)10
Avg EPS beat(12)12.69%
EPS beat(16)13
Avg EPS beat(16)10.59%
Revenue beat(2)2
Avg Revenue beat(2)12.25%
Min Revenue beat(2)11.69%
Max Revenue beat(2)12.81%
Revenue beat(4)4
Avg Revenue beat(4)9.78%
Min Revenue beat(4)1.36%
Max Revenue beat(4)13.28%
Revenue beat(8)5
Avg Revenue beat(8)5.19%
Revenue beat(12)7
Avg Revenue beat(12)3.36%
Revenue beat(16)9
Avg Revenue beat(16)2.8%
PT rev (1m)7.32%
PT rev (3m)1.32%
EPS NQ rev (1m)0.6%
EPS NQ rev (3m)11.57%
EPS NY rev (1m)11.56%
EPS NY rev (3m)17.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.16%
Revenue NY rev (1m)5.73%
Revenue NY rev (3m)5.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.02 | ||
| Fwd PE | 9.64 | ||
| P/S | 7.72 | ||
| P/FCF | 16.83 | ||
| P/OCF | 16.62 | ||
| P/B | 27.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)5.18
EY6.66%
EPS(NY)8.07
Fwd EY10.38%
FCF(TTM)4.62
FCFY5.94%
OCF(TTM)4.68
OCFY6.02%
SpS10.08
BVpS2.84
TBVpS-3.85
PEG (NY)0.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROCE | 35.56% | ||
| ROIC | 28.55% | ||
| ROICexc | 39.96% | ||
| ROICexgc | 93.15% | ||
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% | ||
| FCFM | 45.87% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
ROICexc(3y)23.94%
ROICexc(5y)N/A
ROICexgc(3y)71.73%
ROICexgc(5y)N/A
ROCE(3y)22.19%
ROCE(5y)37.11%
ROICexcg growth 3Y-1.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-28.16%
ROICexc growth 5YN/A
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
F-Score8
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.97 | ||
| Cap/Depr | 8.67% | ||
| Cap/Sales | 0.6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.66% | ||
| Profit Quality | 97.02% | ||
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 | ||
| Altman-Z | 5.62 |
F-Score8
WACC8.98%
ROIC/WACC3.18
Cap/Depr(3y)13.62%
Cap/Depr(5y)33.32%
Cap/Sales(3y)1.21%
Cap/Sales(5y)0.98%
Profit Quality(3y)118.15%
Profit Quality(5y)93.9%
High Growth Momentum
Growth
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y47.96%
EPS Next 2Y38.15%
EPS Next 3Y32.51%
EPS Next 5Y17.63%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
Revenue Next Year31.57%
Revenue Next 2Y27.35%
Revenue Next 3Y23.97%
Revenue Next 5Y12.63%
EBIT growth 1Y68.72%
EBIT growth 3Y25.97%
EBIT growth 5YN/A
EBIT Next Year48.84%
EBIT Next 3Y31.32%
EBIT Next 5Y15.57%
FCF growth 1Y84.66%
FCF growth 3Y16.28%
FCF growth 5YN/A
OCF growth 1Y79.07%
OCF growth 3Y16.96%
OCF growth 5YN/A